Clinical Trial Update: A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating the safety and efficacy of BZL101 for metastatic breast cancer, sponsored by Bionovo. Current trial status is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BZL101

Snippet

Sponsor: Bionovo | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN